[go: up one dir, main page]

CL2008003262A1 - Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish. - Google Patents

Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.

Info

Publication number
CL2008003262A1
CL2008003262A1 CL2008003262A CL2008003262A CL2008003262A1 CL 2008003262 A1 CL2008003262 A1 CL 2008003262A1 CL 2008003262 A CL2008003262 A CL 2008003262A CL 2008003262 A CL2008003262 A CL 2008003262A CL 2008003262 A1 CL2008003262 A1 CL 2008003262A1
Authority
CL
Chile
Prior art keywords
nocardia
seriouslae
combat
vaccine
fish
Prior art date
Application number
CL2008003262A
Other languages
Spanish (es)
Inventor
Laura Labrie
Chow Yong Ng
Fong Sian Wong
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2008003262A1 publication Critical patent/CL2008003262A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.

CL2008003262A 2007-11-02 2008-10-30 Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish. CL2008003262A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07119868 2007-11-02

Publications (1)

Publication Number Publication Date
CL2008003262A1 true CL2008003262A1 (en) 2009-06-26

Family

ID=39769302

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003262A CL2008003262A1 (en) 2007-11-02 2008-10-30 Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.

Country Status (5)

Country Link
JP (1) JP5175940B2 (en)
CN (1) CN101868248A (en)
AU (1) AU2008320818A1 (en)
CL (1) CL2008003262A1 (en)
WO (1) WO2009056629A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011073990A (en) * 2009-09-29 2011-04-14 Meiji Seika Kaisha Ltd Dna vaccine and bcg vaccine against nocardiosis in marine fish
CN102166350B (en) * 2011-04-13 2012-11-21 中国水产科学研究院黄海水产研究所 Flounders quintuplet inactivated vaccine and preparation method thereof
CN103495159B (en) * 2013-09-17 2016-07-06 中国科学院水生生物研究所 The preparation method of flavobacterium columnare genetic vaccine
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia lake virus vaccines
CN104232535B (en) * 2014-09-02 2017-04-26 广东海洋大学 Nocardia seriolae induced low virulent strain and application thereof
CN106754488A (en) * 2016-11-30 2017-05-31 广西南宁市武鸣明山红农业科技开发有限公司 A kind of Streptococcus iniae disease biological agent and preparation method and application
CN107602685B (en) * 2017-11-03 2020-09-15 宁波大学 A polypeptide with antibacterial properties isolated from silver pomfret
CN109880766B (en) * 2019-03-18 2021-05-07 宁波大学 Photobacterium pomfret mermaid strain and inactivated vaccine
CN110250047B (en) * 2019-06-14 2021-12-17 中国水产科学研究院南海水产研究所 Method for industrially culturing eleutheronema tetradactylum
CN112481183A (en) * 2020-12-07 2021-03-12 广东海洋大学深圳研究院 Nocardia seriolae attenuated as well as construction method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001342140A (en) * 2000-03-29 2001-12-11 Gotoo Yoshoku Kenkyusho:Kk Medicine and feed for fish and crustacean
JP2001342141A (en) * 2000-03-29 2001-12-11 Gotoo Yoshoku Kenkyusho:Kk Medicine and feed for aquatic animal and land animal
JP3950924B2 (en) * 2002-04-18 2007-08-01 株式会社三重ティーエルオー Preparation and administration of liposomes containing useful substances for aquatic animals
TWI347364B (en) * 2003-02-19 2011-08-21 Novartis Ag Inactivated nodavirus vaccine
EP1706142B1 (en) * 2003-12-03 2007-04-18 Intervet International BV Streptococcus phocae vaccine
JP4720282B2 (en) * 2005-05-06 2011-07-13 株式会社微生物化学研究所 Fish vaccine

Also Published As

Publication number Publication date
WO2009056629A1 (en) 2009-05-07
JP2011502972A (en) 2011-01-27
CN101868248A (en) 2010-10-20
AU2008320818A1 (en) 2009-05-07
JP5175940B2 (en) 2013-04-03

Similar Documents

Publication Publication Date Title
CL2008003262A1 (en) Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.
CL2013000238A1 (en) Use of succinate dehydrogenase inhibitors and / or complex III inhibitors to improve the relationship between harmful and beneficial microorganisms.
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
CL2011002082A1 (en) Pharmaceutical composition comprising a nucleoside polymerase inhibitor and a macrocyclic protease inhibitor; process to prepare said pharmaceutical composition; method to treat or improve an infection with hepatitis c virus, liver fibrosis and impaired liver function.
BR112017017805A2 (en) composition
BRPI0807132A2 (en) enzymes for the treatment of lignocellulosics, nucleic acids encoding them, and methods and use thereof
BR112012018761A2 (en) structures to prevent microorganism fixation
CL2011002852A1 (en) Use of probiotic lactic acid bacteria by heat treatment for the preparation of compositions for preventing or treating immunodeficiencies caused by bacterial, viral, fungal and / or parasitic infections.
MX2020005875A (en) METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION.
CL2008003712A1 (en) Compounds derived from thiadiazoloxyphenylamidine or thiazolyloxyphenylamidine; its preparation procedure; use and procedure to combat unwanted microorganisms; agent comprising said compounds; intermediate compounds; and its preparation procedure.
CL2008001367A1 (en) Compounds derived from substituted nitrogen heterocycles; preparation process of said compounds; pharmaceutical composition comprising said compounds; and its use to treat a bacterial infection.
CO6640205A2 (en) Microorganisms and methods for the biosynthesis of p-tolute and terephthalate
BR112018074133A2 (en) Bacillus compositions and methods of use with ruminants
GB2518813A (en) OMV vaccine against Burkholderia infections
CL2012002902A1 (en) Specific bacteriophage strains against bacteria belonging to the genus vibrio for the prophylaxis and therapy of vibrio anguillarum; and antibacterial composition comprising said strains.
ES2570990T3 (en) Fermented food containing bifidobacterium bacteria and method to produce it
CL2014002348A1 (en) Phenicol derived compounds; pharmaceutical composition that includes them; and its use to control or treat bacterial infections in cattle.
BR112012032008A2 (en) s100a4 antibodies and therapeutic uses thereof
MX2010000864A (en) Inactivated staphylococcal whole-cell vaccine.
CL2008002371A1 (en) Composition comprising a single-stranded polymer with an immunostimulating RNA motif; method comprising contacting an immune cell capable of producing interferon alpha with said polymer; and methods for treating asthma, an allergic condition, cancer, and an infectious disease.
CL2011002649A1 (en) Use of an aerosol comprising levofloxacin or ofloxacin to prepare a medicament useful for the treatment of a pulmonary bacterial infection.
CU20130044A7 (en) PROCESS FOR THE PREPARATION OF PAN-CDK FORMULA INHIBITORS (I), AND PREPARATION INTERMEDIARIES
UY32488A (en) LIPASA CPO AND DERIVATIVES OF THE SAME
CL2008000856A1 (en) USE OF A MULTOCID MULTIPLE ACAPSULAR AND DIMMED PASTEURELLA TO INDUCE CROSSED IMMUNITY IN AN ANIMAL AGAINST VIRULENT MULTOCIDE P. WHICH HAS A SEROTYPE DIFFERENT FROM MUTING MULTOCIDE P.
BRPI0821025A2 (en) METHOD FOR TREATING BIOMASS, METHOD FOR PRODUCING BIOTANOL, USE OF COMPOSITION AND PROCESSED BIOMASS.